transferred on share sale and purchase date from the seller’s connected persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging
. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator in skin cares and cosmetics. In addition
international sales declined dramatically at 46.03% compared to the same period of the previous year. One of the issues was the delayed product delivery after the license was issued from China Food and Drug
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures
, e.g., supermarket, food and restaurants (only for takeaway), drug stores. Online sales continued to grow remarkably by 150.0% YoY. Gross profit margin from sale of goods improved outstandingly to
. Natural fatty alcohols market in 2019 has slowed down from previous year due to the decline in purchasing power of Chinese consumers who are an important driving force for market, which was affected from US
FX fluctuation normally causes no material impact on overall performance of the company. B.Grimm always has well-planned strategies to manage the FX risk as follows; 1) Natural hedging where the ratio
them cheaper than B7, providing by the Oil Fuel Fund. Natural fatty alcohols market in 1Q2020 moved downward from 1Q2019 affected by the coronavirus (COVID-19) outbreak. Many countries have been imposing
the Company and for the benefit of all its stakeholders. Timely diversification has also helped the Company create a natural hedge against margins volatility seen in a particular product or region